Theraclion completes first varicose veins study
• Join a WEB conference on June 18, 3pm CET covering:
– Interim safety & efficacy results
– Physician feedback
– Regulatory strategy for CE & FDA filing
– Market potential
Theraclion announces a major milestone in its efforts to enter into the varicose veins market: the last patient of the CE marking study has been treated.